Bioinformatics News Oct 2007: bioinformatics, genomics, proteomics, microarray, etc.

Previous 1 2 3 4 5 6 7 Next

Celera Completes Acquisition of Berkeley HeartLab, Inc.
ALAMEDA, Calif.----Celera , an Applera Corporation business, today announced it has completed the acquisition of Berkeley HeartLab, Inc. , for approximately $195 million in cash. BHL is a cardiovascular healthcare company with a broad portfolio of CLIA certified tests and disease management services focused on the secondary prevention market. (Mon, 15 Oct 2007 11:00:00 GMT)

Celera and Collaborators Identify a Five-Gene Genetic Risk Score(TM) That Predicts Risk of Coronary Heart Disease
ALAMEDA, Calif.----Celera , an Applera Corporation business, today announced the publication of results from the Atherosclerosis Risk in Communities study and two independent case-control studies describing the development of a Genetic Risk Score™ based on five gene variants that predicts risk for coronary heart disease . (Mon, 15 Oct 2007 11:00:00 GMT)

Gene Logic Agrees to Sell Genomics Assets
GAITHERSBURG, Md.----Gene Logic Inc. announced today that it had signed an agreement to sell its Genomics assets to Ocimum Biosolutions Ltd., a global life sciences R&D enabling company. (Mon, 15 Oct 2007 11:00:00 GMT)

New Forensic Toxicology Application from Applied Biosystems/MDS SCIEX Improves Accuracy of Screening for Drugs of Abuse
FOSTER CITY, Calif.----Applied Biosystems , an Applera Corporation business, and its joint venture partner, Sciex, a division of MDS Inc.'s Analytical Technologies business, , today introduced a new, automated toxicology testing application designed to better identify drugs of abuse, such as cocaine, heroin and date rape drugs for forensic investigations. (Mon, 15 Oct 2007 11:00:00 GMT)

Celera and Collaborators Identify a Five-Gene Genetic Risk Score(TM) That Predicts Risk of Coronary Heart Disease
ALAMEDA, Calif.----Celera , an Applera Corporation business, today announced the publication of results from the Atherosclerosis Risk in Communities study and two independent case-control studies describing the development of a Genetic Risk Score based on five gene variants that predicts risk for coronary heart disease . (Mon, 15 Oct 2007 11:00:00 GMT)

Luminex Corporation Reaches Settlement With Rules Based Medicine, Inc.
Luminex Corporation today announced that it has settled the pending litigation with Rules Based Medicine, Inc . (Mon, 15 Oct 2007 12:21:00 GMT)

Leuchemix Announces Publication of Data On Its Lead Cancer Drug Candidate
MUKILTEO, Wash., Oct. 15, 2007 -- CombiMatrix Corporation announced that Leuchemix , Inc. has reported the publication of pre-clinical data regarding its lead oncology drug candidate LC-1 in the publication, "Blood," which is the official journal of the American Society of Hematology. (Mon, 15 Oct 2007 13:00:00 GMT)

Microarray sequence capture speeds large-scale resequencing of targeted genomic regions
Researchers at Baylor College of Medicine and Roche NimbleGen Inc., a fully integrated part of Roche Applied Science, today have published details of a highly efficient and cost-effective method for capturing targeted regions of the genome via NimbleChip™ microarrays in preparation for high-throughput 454 Sequencing™. (Mon, 15 Oct 2007 13:14:29 GMT)

Gene Logic to Sell Genomics Arm to Ocimum for $10M; Retains Rights to Use IP for Repositioning Business
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Mon, 15 Oct 2007 14:27:16 GMT)

Gene Logic to Sell Assets for $10M
Gene Logic Inc., a provider of drug development services, said Monday it agreed to sell its genomics assets to India's Ocimum Biosolutions Ltd. for $10 million in cash. (Mon, 15 Oct 2007 14:58:34 GMT)

DNA Sequencing Becomes Much Quicker
A new DNA sequencing process is simpler, more accurate and efficient than the multiplex PCR that was previously used to sequence portions of the genome. Microarrays are used to enrich or increase the volume of specific genomic sequences. Then high throughput DNA sequencing machines quickly determine the exact genetic code of the material. (Mon, 15 Oct 2007 15:06:39 GMT)

Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to ...
Agendia BV, world leader in the rapidly evolving field of molecular diagnostics, announced today that it has acquired the rights to the discovery of a major mechanism of resistance to the frequently-used breast cancer drug Herceptin®, which is published in the October 15 issue of the journal "Cancer Cell". (Mon, 15 Oct 2007 15:35:00 GMT)

New Method Of Selecting DNA For Resequencing Accelerates Discovery Of Subtle DNA Variations
A new technology developed by scientists at Emory University will allow researchers to more easily discover subtle and overlooked genetic variations that may have serious consequences for health and disease (Mon, 15 Oct 2007 15:50:06 GMT)

Empire Genomics And Reprogenetics Join Forces To Improve Preimplantation Genetic Diagnosis (PGD)
Empire Genomics, developing high throughput technologies that enable genome-wide analyses, and Reprogenetics, a genetics laboratory specializing in Preimplantation Genetic Diagnosis (PGD), announce data supporting a new technique to significantly improve the identification of genetic and chromosomal abnormalities from just a single or small group of embryonic cell(s) (Mon, 15 Oct 2007 16:05:06 GMT)

Gene Logic sells genomics division
Gene Logic Inc. has agreed to sell its genomics business to research and development firm Ocimum Biosolutions Ltd. for $10 million. (Mon, 15 Oct 2007 16:06:47 GMT)

Gene Logic sells genomics division
Gene Logic Inc. has agreed to sell its genomics business to research and development firm based in India for $10 million. (GLGC) (Mon, 15 Oct 2007 16:18:50 GMT)

Biopharmaceutical Infrastructure Key to Lower Drug Development Costs
Improvements to the technology infrastructure for researching and developing new biopharmaceuticals could save the industry hundreds of millions of dollars annually, according to a new study conducted by RTI International for the National Institute of Standards and Technology (NIST). (Mon, 15 Oct 2007 16:25:34 GMT)

Power3 makes first deal on breast cancer test
Power3 Medical Products Inc. said Monday that it has made its first distribution agreement for its BC-SeraPro breast cancer blood serum diagnostic test. (Mon, 15 Oct 2007 16:59:37 GMT)

New method of selecting DNA developed
A new technology developed by U.S. scientists will allow researchers to more easily select DNA for resequencing. (Mon, 15 Oct 2007 17:12:16 GMT)

Biopharmaceutical Infrastructure Key to Lower Drug Development Costs
Improvements to the technology infrastructure for researching and developing new biopharmaceuticals would be expected to save the industry hundreds of millions of dollars annually, according to a new economic study sponsored by NIST. (Mon, 15 Oct 2007 17:25:35 GMT)

New method of selecting DNA developed
A new technology developed by U.S. scientists will allow researchers to more easily select DNA for resequencing. Emory University researchers said their new technique will help other scientists discover subtle and overlooked genetic variations that might have serious consequences for health and disease. The protocol -- called Microarray-based Genomic Selection, or MGS -- allows scientists to ... (Mon, 15 Oct 2007 17:42:13 GMT)

Microarray-based genomic selection accelerates discovery of subtle DNA variations
A new technology developed by scientists at Emory University will allow researchers to more easily discover subtle and overlooked genetic variations that may have serious consequences for health and disease. (Mon, 15 Oct 2007 20:03:26 GMT)

Lignol Announces Participation in Industry Conferences
Lignol Energy Corporation announced today its participation in the following industry conferences over the next several months: (Mon, 15 Oct 2007 21:03:00 GMT)

Engineers work on real-time control of artificial limbs
Researchers have reported advances in neural technology as well as the hurdles still ahead for delivering capabilities such as artificial limbs powered by implanted devices that read and harness subtle control signals in the brain. (Mon, 15 Oct 2007 21:09:12 GMT)

Local News Genesis Genomics strikes landmark retail deal
For the past five years Genesis Genomics has been on the cutting edge of biotechnology research at the molecular level. Now the company will soon find itself on the cutting edge of skin care at the retail level. (Mon, 15 Oct 2007 22:01:12 GMT)

Researchers Discover Antibody Used to Detect Diabetes
Researchers at the Barbara Davis Center for Childhood Diabetes and University of Colorado at Denver and Health Sciences Center's School of Medicine have discovered a fourth antibody in human blood which will help more accurately predict who is predisposed to type 1 diabetes. The findings will be posted online the week of Oct. 15 and will be published in the Oct. 23 issue of the Proceedings of ... (Mon, 15 Oct 2007 22:26:04 GMT)

Gene Logic is exiting genomics
In a deal that would leave Gene Logic Inc. with an entirely new identity, the Gaithersburg firm Monday said it has accepted a $10 million offer for the genomics business on which it was founded. (Mon, 15 Oct 2007 22:47:42 GMT)

Accuracy Of Breast Cancer Prognoses Improved
One of the many unknowns facing women who are diagnosed with breast cancer is predicting the likelihood that the cancer will spread to other parts of the body -- metastasize. Researchers are looking to change that. They are pioneering a more accurate approach for predicting the risk of breast cancer metastasis in individual patients. (Tue, 16 Oct 2007 01:06:38 GMT)

Internet fuels global learning community
University of Pittsburgh epidemiologist Ron LaPorte said humanity benefits when the world's leading researchers share information about disease prevention. ... (Tue, 16 Oct 2007 04:21:47 GMT)

Expert on Alzheimer's Detection Says Simple Blood Test for Alzheimer's Closer than Reported
Stanford University researchers stated they are developing a blood test that could be used to identify patients with Alzheimer's disease, according to a paper published by the British journal, Nature Medicine. For those covering today's news, Power3 Medical Products, Inc. makes available Dr. Ira Goldknopf, director of proteomics of Power3 Medical Products, Inc. (Tue, 16 Oct 2007 04:25:49 GMT)

Rosetta Biosoftware's Rosetta Syllego System Achieves GeneChip-compatible(TM) Status with the Affymetrix GeneChip(R) ...
Rosetta Biosoftware, a leader in life science informatics solutions, today announced that the Rosetta Syllego(TM) system has achieved GeneChip-compatible(TM) status for use with the Affymetrix microarray platform. (Tue, 16 Oct 2007 05:00:00 GMT)

Obesity genetics
New evidence that genetics plays a key role in obesity is published today in the International Journal of Bioinformatics Research and Applications. The findings relate to the genetics of modern Pima Indians who have an unusually high rate of obesity but could be extrapolated to all people. (Tue, 16 Oct 2007 05:11:44 GMT)

To The POINT With Michael Parsons
AS IMMEDIATE Past President of the Rotary Club of Hunters Hill, I was proud to present a cheque for $5000 recently to Dr Kerrie McDonald of the Kolling Institute to fund brain tumour research. (Tue, 16 Oct 2007 06:00:42 GMT)

CU makes breakthrough in type 1 diabetes
University of Colorado researchers have discovered an anti-body in human blood that can predict who is predisposed to type 1 diabetes, a breakthrough that could lead to the elimination of the disease. (Tue, 16 Oct 2007 07:18:47 GMT)

Gene Logic sells signature gene-mapping division
Gene Logic Inc., a Gaithersburg biotech, said yesterday that it will sell its genomics information division, officially exiting the gene mapping business the company was founded on more than a decade ago. (Tue, 16 Oct 2007 07:27:04 GMT)

No more surprises! Communicaid offers SafetyNet(TM) for Near-Perfect Translation
SAN JOSE, Calif.----When near perfect translation and consistency of numeric content is needed, customers will want Communicaid's SafetyNet Numeric Proofing Tool. It should be on every localization customer's wish list. (Tue, 16 Oct 2007 08:04:00 GMT)

Obesity genetics
New evidence that genetics plays a key role in obesity is published today in the International Journal of Bioinformatics Research and Applications. (Tue, 16 Oct 2007 08:14:57 GMT)

Microarray Sequence Capture Speeds Large-Scale Resequencing Of Targeted Genomic Regions
Researchers at Baylor College of Medicine and Roche NimbleGen Inc., a fully integrated part of Roche Applied Science, have published details of a highly efficient and cost-effective method for capturing targeted regions of the genome via NimbleChip(TM) microarrays in preparation for high-throughput 454 Sequencing(TM). [click link for full article] (Tue, 16 Oct 2007 08:15:48 GMT)

Scientists Discover New Molecular Markers for Testicular Cancer
ROTTERDAM, Netherlands & FOSTER CITY, Calif.----Scientists at the Erasmus MC-University Medical Center in Rotterdam, The Netherlands and Applied Biosystems , an Applera Corporation business, have made significant advances in testicular cancer research by identifying and analyzing a set of specific microRNA molecular markers that are involved in the development of testicular tumors. (Tue, 16 Oct 2007 11:30:00 GMT)

Metabolomic Profiling Accurately Identifies Stages of Oocyte Maturation in IVF
Molecular Biometrics, a privately held metabolomics company, presented results of a clinical study investigating the use of metabolomic profiling to establish the maturational stage of oocytes. (Tue, 16 Oct 2007 12:01:00 GMT)

Genetics Has Key Role In Obesity
A new line of evidence ties the risk of obesity to genetics. The modern Pima Indians have an unusually high rate of obesity but the new findings could be extrapolated to other populations. (Tue, 16 Oct 2007 12:06:38 GMT)

Molecular Nutrition Report Presents a Vital Portrait of the Fundamental Role That Nutrition Has Played in Human ...
DUBLIN, Ireland----Research and Markets has announced the addition of "Molecular Nutrition and Genomics: Nutrition and the Evolution of Humankind" to their offering. (Tue, 16 Oct 2007 12:55:00 GMT)

Progeniq Joins Microsoft in BioIT Alliance
... Empowers Life Sciences Community with accelerated BioInformatics... SINGAPORE - September 26, 2007 - Microsoft Corp., announced the initiation of Progeniq Pte Ltd, a leader in reconfigurable computing applications headquartered in Singapore, into the BioIT Alliance today. The BioIT Alliance is a cross-industry group working to integrate science and technology to accelerate the pace of drug ... (Tue, 16 Oct 2007 13:03:37 GMT)

Rosetta Biosoftware's Rosetta Syllego System Achieves GeneChip-compatible(TM) Status with the Affymetrix GeneChip(R) ...
Rosetta Biosoftware, a leader in life science informatics solutions, today announced that the Rosetta Syllego â„¢ system has achieved GeneChip-compatible TM status for use with the Affymetrix ( Nachrichten ) microarray platform. (Tue, 16 Oct 2007 15:09:29 GMT)

Researchers Improve Accuracy Of Breast Cancer Prognoses
One of the many unknowns facing women who are diagnosed with breast cancer is predicting the likelihood that the cancer will spread to other parts of the body -- metastasize. Researchers from UC San Diego are looking to change that. UCSD bioengineering professor Trey Ideker is pioneering a more accurate approach for predicting the risk of breast cancer metastasis in individual patients. [click ... (Tue, 16 Oct 2007 17:16:08 GMT)

Alberta BioIndustry projects revenues to jump 400 percent in next three years
The bio sector in Alberta is expected to grow significantly - according to a joint survey presented today by BioAlberta and KPMG LLP. (Tue, 16 Oct 2007 17:30:00 GMT)

BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization
BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, announced today the release of NEXUS CGH version 2, the first commercial software tool that provides easy, fast and powerful platform independent and cross-platform analysis of multiple array based DNA copy number data sets, simultaneously. (Tue, 16 Oct 2007 20:17:00 GMT)

BIOBASE Reaches Milestone of Longevity in ''Young'' Industry
WOLFENBUTTEL, Germany and BEVERLY, Mass.----BIOBASE announced today that it has reached a milestone few other bioinformatics companies have achieved, it is ten years old. This makes it one of the oldest and most respected providers of biological databases in the world. (Tue, 16 Oct 2007 21:00:00 GMT)

Publication In PNAS Utilizes Invitrogen's ProtoArray(R) Technology to Discover Novel Candidate Ovarian Cancer Biomarkers
CARLSBAD, Calif.----Invitrogen Corporation , a provider of essential life science technologies for research, production and diagnostics, today announced the publication of a study in the journal of Proceedings of National Academy of Sciences that applies the company's ProtoArray® technology to identify new autoantigens associated with ovarian cancer. (Tue, 16 Oct 2007 21:00:00 GMT)

Dawn Of Animal Vision Discovered
By peering deep into evolutionary history, scientists have discovered the origins of photosensitivity in animals. The researcher said that anti-evolutionists often argue that mutations, which are essential for evolution, can only eliminate traits and cannot produce new features. He goes on to say, "Our paper shows that such claims are simply wrong. We show very clearly that specific mutational ... (Wed, 17 Oct 2007 02:06:38 GMT)

Ocimum Bioslutions to buy Gene Logic's genomic business
Ocimum Biosolutions Inc, here on Monday, announced that it had agreed to buy Gene Logic's genomics business for $10 million in cash. (Wed, 17 Oct 2007 02:42:43 GMT)

Two eminent scientists join A*Star to boost research in S'pore
TWO eminent scientists, Professor Paola Ricciardi-Castagnoli and Dr Frank Eisenhaber, have joined Singapore's Agency for Science, Technology and Research (A*Star) to provide scientific leadership and to widen the global linkages for the Singapore Immunology Network (SIgN) and the Bioinformatics Institute (BII). (Wed, 17 Oct 2007 03:38:16 GMT)

At last, the chips are up at state bioscience firm
When Alex Vodenlich came to GenTel BioSciences Inc. in February 2003, he assumed the company was well-positioned for swift growth. (Wed, 17 Oct 2007 03:57:02 GMT)

AnaSpec Introduces Labeled RGD Peptide for In Vivo Imaging AnaSpec Inc. Posted on: 16 Oct 07
Leveraging its dual expertise in peptides and detection reagents, AnaSpec has released c[RGDyK(HiLyte FluorTM 750)], a labeled RGD peptide that has produced significant imaging results in a recent in vivo research study. (Wed, 17 Oct 2007 08:41:55 GMT)

The Biggest Opportunity Area In The Bioinformatics Market Will Be In The Drug Discovery Sector
DUBLIN, Ireland----Research and Markets has announced the addition of "Global Bioinformatics Market Outlook" to their offering. (Wed, 17 Oct 2007 09:42:00 GMT)

Two experts in immunology, bioinformatics join A*STAR
SINGAPORE: Two eminent scientists have joined the Agency for Science, Technology and Research (A*STAR), giving a boost to its immunology and bioinformatics expertise. (Wed, 17 Oct 2007 11:45:42 GMT)

Affymetrix Launches Microarray Data Analysis Training University
Affymetrix Inc. ( Nachrichten ) (Nasdaq: AFFX) announced today the launch of Affymetrix University, a series of hands-on data analysis training courses that will be held in various locations throughout Europe and North America. (Wed, 17 Oct 2007 12:20:11 GMT)

Affymetrix launches education effort
Affymetrix Inc. said Wednesday it launched Affymetrix University, a series of courses that will be held throughout Europe and North America. (Wed, 17 Oct 2007 14:11:57 GMT)

Baicalin might be a promising therapeutic tool for severe acute pancreatitis
¡°Qingyitang¡±, a representative prescription of Traditional Chinese Medicine for SAP was widely used in the orients countries. But its real pharmacological mechanisms of protective effects on SAP have not been investigated still now. (Wed, 17 Oct 2007 14:16:22 GMT)

Ludesi Presents Results From Scientific Study on Discovery Potential in 2D Gel Image Analysis at the International ...
Ludesi AB, provider of the industry-leading Image Analysis Service for 2-dimensional electrophoresis gels, presented results from an extensive study on how to optimize discovery potential in 2D gel image analysis at the International HUPO conference held in Seoul, South Korea last week. (Wed, 17 Oct 2007 14:49:00 GMT)

The Genetics Of Obesity
New evidence that genetics plays a key role in obesity is published in the International Journal of Bioinformatics Research and Applications. The findings relate to the genetics of modern Pima Indians who have an unusually high rate of obesity but could be extrapolated to all people. [click link for full article] (Wed, 17 Oct 2007 15:16:49 GMT)

Massive MicroRNA Scan Uncovers Leads To Treating Muscle Degeneration
An increasing number of genes have been linked to muscular dystrophy and related disorders that cause muscle weakness and wasting, but it's still largely unknown how these genes cause disease, and, more importantly, how to translate the discoveries into treatments. A wealth of new clues about how muscle function is regulated has been found by analyzing microRNAs -- tiny bits of code that govern ... (Wed, 17 Oct 2007 16:07:18 GMT)

The Virginia G. Piper Charitable Trust and Flinn Foundation Launch $45 million Initiative to Develop Personalized ...
PHOENIX----Two Arizona-based philanthropic organizations have committed $45 million to fund an innovative initiative to develop personalized molecular diagnostics. The ability to diagnose and treat disease based on every person's unique physiological makeup is critical to enabling physicians to improve health outcomes while at the same time reducing medical costs. (Wed, 17 Oct 2007 17:00:00 GMT)

TGen, ASU receive $45 million, secure Nobel laureate
The Translational Genomics Research Institute and Arizona State University received a $45 million infusion and secured a Nobel laureate to oversee a new venture to develop personalized diagnostics. (Wed, 17 Oct 2007 17:04:41 GMT)

Synthetic Genomics | Options for Governance
Gene and genome synthesis, that is, constructing long stretches of DNA from constituent chemicals, provides scientists with new and unparalleled capabilities both for understanding biology and for using it for beneficial purposes. But along with new capabilities come new risks. (Wed, 17 Oct 2007 17:17:49 GMT)

T-Bay R & D firm strikes deal with skin care company
Thunder Bay biotech company Genesis Genomics is partnering with VitalScience, a Woodbridge, Ont.-based skin care company, to produce and market a DNA skin test developed in the North. (Wed, 17 Oct 2007 18:02:20 GMT)

Genetics play a key role in obesity
New evidence that genetics plays a key role in obesity is published today in the International Journal of Bioinformatics Research and Applications. (Wed, 17 Oct 2007 19:48:04 GMT)

CombiMatrix Corporation to Release Third Quarter Financial Results and Host Conference Call
MUKILTEO, Wash., Oct. 17, 2007 -- CombiMatrix Corporation announced today that it will release its third quarter financial results on Wednesday, October 24, 2007. Results will be released at the close of trading on that day. (Wed, 17 Oct 2007 20:00:00 GMT)

JCVI, MIT, CSIS Call for Synthetic Genomics Policy that Balances Safety, Flexibility
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Wed, 17 Oct 2007 20:13:08 GMT)

Personal genomics: His daughter's DNA
Despite a training in clinical genetics, Hugh Rienhoff didn't know what was wrong with his daughter. So, as he tells Brendan Maher, he set about finding out. (Wed, 17 Oct 2007 21:06:17 GMT)

Alpha Innotech and R&C Biogenius Ltd. Announce a New Imaging Instrument Development and Supply Agreement
SAN LEANDRO, Calif.----Alpha Innotech Corp. , a leading provider of bioanalytical systems for drug discovery and life science research, announced today that it has established a product development and OEM supply agreement with R&C Biogenius Ltd. (Thu, 18 Oct 2007 00:08:00 GMT)

Baylor Research Institute to Collaborate with Mount Sinai School of Medicine to Develop Therapeutic Cancer Vaccines
Officials with Baylor Research Institute and the Mount Sinai School of Medicine announced today that the institutions are collaborating to develop therapeutic cancer vaccines for patients with lymphoma and myeloma, both cancers that affect the immune system. Additionally, the researchers will investigate ways to better diagnose autoimmune disorders such as arthritis and lupus. (Thu, 18 Oct 2007 04:25:34 GMT)

Institute to seek a cure - just for you
Two Arizona philanthropic groups contribute $45 million to develop a new research initiative for personalized medicine. The goal is to develop blood-based tests and predict and help prevent disease. (Thu, 18 Oct 2007 07:09:22 GMT)

New approach to medicine will take personalized approach
A new approach to medicine that emphasizes personalized treatment based on each patient's unique physiological makeup was announced Wednesday by two Valley philanthropic organizations. (Thu, 18 Oct 2007 09:13:40 GMT)

DNA Analysis goes commercial. Video
DNA analysis is now available on a commercial level. Ancestry.com and Sorenson Genomics have teamed up to offer DNA results to individuals. (88 sec./3.31Mb, shows: 0) (Thu, 18 Oct 2007 09:44:04 GMT)

Applied Biosystems to Webcast Investor Q&A on SOLiDTM Next-Generation DNA Sequencing System During the American ...
FOSTER CITY, Calif.----Applied Biosystems Group , an Applera Corporation business, will webcast a meeting with investors on Thursday, October 25, 2007. The one-hour question and answer session, which will be held during the American Society of Human Genetics annual meeting in San Diego, is scheduled to begin at 11:00 a.m. (Thu, 18 Oct 2007 11:00:00 GMT)

'The Cancer Clock' Offers a Comprehensive Overview of the World's Second Biggest Killer
Research and Markets (http://www.researchandmarkets has announced the addition of The Cancer Clock to their offering. (Thu, 18 Oct 2007 11:50:00 GMT)

'The Cancer Clock' Offers a Comprehensive Overview of the World's Second Biggest Killer
DUBLIN, Ireland----Research and Markets has announced the addition of The Cancer Clock to their offering. (Thu, 18 Oct 2007 11:50:00 GMT)

Invitrogen Now Co-Exclusive Worldwide Distributor of Blue Heron Biotechnology Custom Gene Synthesis Services
CARLSBAD, Calif.----Invitrogen Corporation , a provider of essential life science technologies for research, production and diagnostics, has reached a key milestone in its agreement with Blue Heron Biotechnology and is now the co-exclusive worldwide distributor with Blue Heron for its custom gene synthesis services. (Thu, 18 Oct 2007 12:00:00 GMT)

Bruker Companies Announce the Opening of a Modern Chinese Applications, Demonstration and Customer Training Center in ...
BEIJING----During the BCEIA 2007 conference, Bruker BioSciences Corp. and the Bruker BioSpin group of companies today announced the official opening of their new Beijing modern applications, demonstration and customer training laboratory, showcasing a wide selection of novel life science and materials research, as well as industrial analysis systems. (Thu, 18 Oct 2007 13:15:00 GMT)

Baicalin Has Potential To Be A Therapeutic Tool For Severe Acute Pancreatitis
'Qingyitang', a representative prescription of Traditional Chinese Medicine for SAP was widely used in the oriental countries but its real pharmacological mechanisms of protective effects on SAP have not been investigated until now. [click link for full article] (Thu, 18 Oct 2007 13:16:18 GMT)

Development Of Personalized Molecular Diagnostics To Improve Patient Outcomes And Reduce Healthcare Costs
Two Arizona-based philanthropic organizations have committed $45 million to fund an innovative initiative to develop personalized molecular diagnostics. The ability to diagnose and treat disease based on every person's unique physiological makeup is critical to enabling physicians to improve health outcomes while at the same time reducing medical costs. [click link for full article] (Thu, 18 Oct 2007 13:17:02 GMT)

Commission hears UB testimony
The role of UB as a major player in bioinformatics and life sciences innovation in Western New York was one of the topics of discussion during a public hearing convened Oct. 11 by the New York State Commission on Higher Education. (Thu, 18 Oct 2007 14:43:56 GMT)

Scientists Discover New Molecular Markers For Testicular Cancer
Scientists at the Erasmus MC-University Medical Center in Rotterdam, The Netherlands and Applied Biosystems (NYSE:ABI), an Applera Corporation business, have made significant advances in testicular cancer research by identifying and analyzing a set of specific microRNA molecular markers that are involved in the development of testicular tumors. [click link for full article] (Thu, 18 Oct 2007 15:16:08 GMT)

Arizona bioscience leaders boosted by Nobel laureate, $45 million
PHOENIX (AP) -- Arizona scientists hope a $45 million donation and a Nobel Prize winner can help them improve health care and make it cheaper for everyone. (Thu, 18 Oct 2007 15:31:12 GMT)

Health Discovery receives notice of allowance of U.S. patent application covering kernel selection methods
Health Discovery Corporation has announced that the U.S. Patent and Trademark Office has issued a notice of allowance of HDC's patent application covering methods for selection of kernels, i.e., functions or algorithms that are used to transform input data into a different configuration, known as "feature space", which allows for easier recognition of patterns within the data. (Fri, 19 Oct 2007 00:17:14 GMT)

Massive microRNA scan uncovers leads to treating muscle degeneration
Researchers have discovered the first microRNAs - tiny bits of code that regulate gene activity - linked to each of 10 major degenerative muscular disorders, opening doors to new treatments and a better biological understanding of these debilitating, poorly understood, often untreatable diseases. (Fri, 19 Oct 2007 00:47:40 GMT)

Baicalin shows promise for severe acute pancreatitis
¡°Qingyitang¡±, a representative prescription of Traditional Chinese Medicine for SAP was widely used in the orients countries. (Fri, 19 Oct 2007 02:17:54 GMT)

In Microbe, Vast Power For Biofuel
QUABBIN RESERVOIR, Mass. Ten years ago, an assistant from a microbiology laboratory took a hike near the shore of the vast Quabbin Reservoir, which supplies water to Boston. At one point, he crouched alongside a brook in the shade of towering hemlock trees, dug up some moist dirt, put it in a jar... (Fri, 19 Oct 2007 05:49:01 GMT)

$45M may hatch special center
PHOENIX - Arizona scientists hope a $45 million donation and a Nobel Prize winner can help them improve health care and make it cheaper for everyone. (Fri, 19 Oct 2007 07:09:13 GMT)

U.S. Oncology Initiates Complete Phase Ib Trial Of Brostallicin Combination Therapy In Advanced Solid Tumors
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTAX: CTIC) and Systems Medicine, LLC (SM), a wholly-owned subsidiary of CTI, announced the enrollment of the first patient to its complete phase Ib trial of brostallicin used in combination with either bevacizumab or irinotecan, for patients with advanced solid tumors. [click link for full article] (Fri, 19 Oct 2007 08:18:09 GMT)

Celera Genomics "market underperform," target price raised
NEW YORK, October 19 (newratings.com) - Analysts at JMP Securities reiterate their "market underperform" rating on Celera Genomics Group ( CRA.NYS ), while raising their estimates for the company. The target price has been raised from $11 to $13. (Fri, 19 Oct 2007 12:37:02 GMT)

Software facilitates metabolomic data analysis.
Offered as complete solution within Ingenuity Pathways Analysis, IPA-Metabolomics(TM) enables researchers to identify pathways and biological processes most relevant to metabolomic data. Information is relayed within context of dynamic signaling and metabolic pathways, and this integration helps users identify emergent principles for generating testable hypotheses in continuing refinement of ... (Fri, 19 Oct 2007 13:04:08 GMT)

Proteomics Standard meet dynamic range needs of researchers.
With Proteomics Dynamic Range Standard UPS2, researchers can verify, challenge, and troubleshoot proteomics strategy as well as compare results with other labs. It includes 48 human proteins that have been HPLC-purified and formulated into dynamic range of concentrations from 0.5 fmoles to 50 pmoles. This story is related to the following: Services (Fri, 19 Oct 2007 13:07:04 GMT)

Publication In PNAS Utilizes Invitrogen's ProtoArray Technology To Discover Novel Candidate Ovarian Cancer Biomarkers
Invitrogen Corporation, a provider of essential life science technologies for research, production and diagnostics, announced the publication of a study in the journal of Proceedings of National Academy of Sciences (PNAS) that applies the company's ProtoArray technology to identify new autoantigens associated with ovarian cancer (Fri, 19 Oct 2007 13:20:16 GMT)

Biopharmaceutical Infrastructure Key To Lower Drug Development Costs
Improvements to the technology infrastructure for researching and developing new biopharmaceuticals would be expected to save the industry hundreds of millions of dollars annually, according to a new economic study* sponsored by the National Institute of Standards and Technology (NIST) (Fri, 19 Oct 2007 13:20:26 GMT)

Waters Systems Biology Solutions Brochure "IdentityE High Definition Proteomics" Now Available
Waters Corporation announced today the availability of a new brochure, "IdentityE High Definition Proteomics." This brochure provides researchers with information on the latest tools for reliable and consistent protein identifications (Fri, 19 Oct 2007 14:19:56 GMT)

Craig Venter: Google your date's DNA
Genetics pioneer Craig Venter has news from the frontiers of biology. (Fri, 19 Oct 2007 16:51:29 GMT)

Web 2.0 Summit: Google The DNA Of Prospective Mates?
Genetic pioneer J. Craig Venter said his experience in posting his body's own code online means it's time to rethink human genetics. (Fri, 19 Oct 2007 18:11:00 GMT)

Newbury Piret & Co. Represents Isolation Technologies in Its Sale to IDEX Corporation
Newbury Piret & Co., Inc. is pleased to announce that its client, Isolation Technologies, Inc., a leading developer of advanced column hardware and accessories for the High Performance Liquid Chromatography market, has been acquired by IDEX Corporation . (Fri, 19 Oct 2007 18:40:00 GMT)

Newbury Piret & Co. Represents Isolation Technologies in Its Sale to IDEX Corporation
BOSTON, Oct. 19 /PRNewswire/ -- Newbury Piret&Co., Inc. is pleased to announce that its client, Isolation Technologies, Inc., a leading developer of advanced column hardware and accessories for the High Performance Liquid Chromatography (HPLC) market, has been acquired by IDEX Corporation ( Nachrichten ) . HPLC instruments are used in a variety of analytical chemistry applications, with primary ... (Fri, 19 Oct 2007 18:48:31 GMT)

Human sewage--the next source of electricity?
Can microbes turn drain water into power? Yes, says a noted genetic scientist. And they can make jet fuel too. (Fri, 19 Oct 2007 20:06:22 GMT)

Biotech Support Group LLC and ProFACT Proteomics Inc., Form a Strategic Alliance to Provide Consulting Services in the ...
Biotech Support Group LLC and ProFACT Proteomics Inc., form a strategic alliance to provide consulting services in the field of profiling serum protein for proteomic analysis by using SeraFILE™ a revolutionary new technology in the field of proteomics. (Sat, 20 Oct 2007 07:01:00 GMT)

Case Of The Lethal Genes Solved By Massive Reanalysis Of Genome Data
It is better to be looked over than overlooked, Mae West supposedly said. These are words of wisdom for genome data-miners of today. Data that goes unnoticed, despite its widespread availability, can reveal extraordinary insights to the discerning eye. Such is the case of a systematic analysis by the U.S. [click link for full article] (Sat, 20 Oct 2007 12:15:28 GMT)

Bacteria Use Plant Defense For Genetic Modification
Bacteria that cause tumors in plants modify plant genomes by skilfully exploiting the plants' first line of defense. Utilizing the plant's own proteins, bacterial genes infiltrate first the nucleus then the plant genome, where they reprogram the plant's metabolism to suit their own needs. This research was published in Science. (Sat, 20 Oct 2007 13:06:38 GMT)

Tassie devils are fighting for survival
Loss of genetic diversity is causing the rapid spread of deadly facial tumours among Tasmanian devils, leaving the animals with no immune response to fight the disease, new research reveals. (Sat, 20 Oct 2007 22:09:48 GMT)

Microbe raises investors' hopes
Ten years ago, an assistant from a microbiology laboratory took a hike near the shore of the vast Quabbin Reservoir, which supplies water to Boston. At one point, he crouched alongside a brook in the shade of towering hemlock trees, dug up some moist dirt, put it in a jar and took it back to the lab. (Sun, 21 Oct 2007 05:49:06 GMT)

Philadelphia hospital seen as model for children's care
PHILADELPHIA - Walk the halls with the world-class researchers here, and around every corner there are glimpses of what is possible if Sanford Health's vision becomes reality. The researchers here talk about killing cancer cells, about finding disease years before it strikes children, about saving lives around the globe. Most of all, they talk about hope. (Sun, 21 Oct 2007 07:06:14 GMT)

Fight drought with GM crops, says agency
The Federal Government's economic research agency has told a conference that genetically-modified (GM) crops need to be part of Australia's solution to drought and climate change problems. (Mon, 22 Oct 2007 03:41:10 GMT)

Google the DNA of prospective mates?
Genetic pioneer J. Craig Venter said his experience in posting his body's own code online means it's time to rethink human genetics.. (Mon, 22 Oct 2007 05:12:38 GMT)

Targeting incredible shrinking cost of genome sequencing
The cost of sequencing the human genome has been shrinking ever since the first genetic blueprint was completed in 2003 for $3 billion. (Mon, 22 Oct 2007 05:22:10 GMT)

Danforth Center gets nearly $1 million grant to study soil fertility
Scientific research that could impact the agricultural industry by hundreds of millions of dollars is in its initial stages at the Donald Danforth Plant Science Center. (Mon, 22 Oct 2007 06:03:21 GMT)

Overseas medical care boosts profit
BALTIMORE - When an Ohio clinic expanded overseas last year, the deal was not about providing health care in an impoverished part of the world. Rather, Cleveland Clinic executives were surrounded by sheiks and a prince as they signed a 15-year agreement to operate a medical center in Abu Dhabi. (Mon, 22 Oct 2007 07:06:28 GMT)

Agilent, BioTrove sign pact for mass spectrometry solution
Agilent Technologies Inc, the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis, and BioTrove Inc. announced that they have signed an agreement to co-market the Agilent 6410 Triple Quadrupole Mass Spectrometer with BioTrove's RapidFire high-throughput sample preparation systems. (Mon, 22 Oct 2007 07:41:53 GMT)

Singapore's Biomedical Sciences Initiative For Clinical Research
Biomedical Sciences International Advisory Council gives full support for Singapore's latest Translational and Clinical Research InitiativesA new partnership to build an integrated neuroscience research programme that spans basic science all the way to clinical research. [click link for full article] (Mon, 22 Oct 2007 08:17:09 GMT)

MIT to study genes' role in mental illness
MIT's McGovern Institute for Brain Research will announce today that it has received $20 million to help crack the biological basis of serious mental illness. (Mon, 22 Oct 2007 08:40:26 GMT)

Bacteria use plant defence for genetic modification
Bacteria that cause tumours in plants modify plant genomes by skilfully exploiting the plants' first line of defence. (Mon, 22 Oct 2007 09:32:45 GMT)

Illumina Launches MicroRNA Assay for Gene Expression Profiling
SAN DIEGO----Illumina, Inc. today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods. (Mon, 22 Oct 2007 10:00:00 GMT)

Ancestry.com introduces DNA testing
Who do you think you are? DNA service plans to fill in the gaps with a thread of evidence (Mon, 22 Oct 2007 11:40:33 GMT)

High-powered research group meeting here to focus on the super-strain of TB.
NEW drugs are needed to fight tuberculosis, which has become increasingly resistant to current drugs. This pressing issue is on the agenda of an international high-powered research grouping at its third annual meeting, which starts on Tuesday. (Mon, 22 Oct 2007 12:08:17 GMT)

Agendia BV Announces That its Chief Research Officer Laura van 't Veer has Received a 2007 Breast Cancer Research ...
Agendia BV, a world leader in the rapidly evolving field of cancer molecular diagnostics, announced today that its Chief Research Officer Laura van 't Veer has received a prestigious 2007 Breast Cancer Research Foundation Award from the Pink Ribbon Breast Cancer Research Foundation. (Mon, 22 Oct 2007 13:00:00 GMT)

Epstein-Barr: a Virtual Look at a Vexing Virus
Researchers have created a computer model called Pathogen Simulation (PathSim) to study the sometimes deadly Epstein-Barr virus (EBV), which infects greater than 90% of the world's population. By using PathSim to study EBV, researchers hope to determine why some infected patients fall ill while others show no symptoms. (Mon, 22 Oct 2007 13:20:09 GMT)

Ancestry.com introduces DNA testing
Who do you think you are? DNA service plans to fill in the gaps with a thread of evidence (Mon, 22 Oct 2007 13:28:39 GMT)

Africa: Protect Africa From Technological Vandalism
The Kenyan parliament is debating a bill to enable the country to regulate agricultural biotechnology. (Mon, 22 Oct 2007 13:46:35 GMT)

Chemical Computing Group Releases the Molecular Operating Environment for the Solaris(TM) 10 Operating System
MONTREAL----Chemical Computing Group Inc. announces the general release of the 2007.09 version of the Molecular Operating Environment for the Solaris™ 10 Operating System from Sun Microsystems Inc. running on UltraSPARC® and x86 architectures. (Mon, 22 Oct 2007 14:11:00 GMT)

Epstein-Barr: a virtual look at a vexing virus
BOSTON (October 22, 2007) — Researchers at Tufts University School of Medicine in collaboration with the Virginia Bioinformatics Institute at Virginia Tech have created a computer program called Pathogen Simulation (PathSim) to study the progression of Epstein-Barr virus (EBV) in humans. (Mon, 22 Oct 2007 14:21:19 GMT)

Luminex Corporation Third Quarter Earnings Release Scheduled for October 24, 2007
Luminex Corporation today announced that it expects to report third quarter results on Wednesday, October 24, 2007. (Mon, 22 Oct 2007 15:00:00 GMT)

Autism Consortium releases data on genes involved in autism to researchers worldwide
BOSTON – OCTOBER 22, 2007 – The Autism Consortium, a group of researchers, clinicians and families dedicated to radically accelerating research and enhancing clinical care for autism, announced today that it has completed the first genome scan for Autism Spectrum Disorders (ASD) through its Autism Gene Discovery Project and has released the reference data set to a database that autism ... (Mon, 22 Oct 2007 16:42:55 GMT)

UAlbany to dedicate new conference center named for Massrys
The state University at Albany is dedicating what it's calling the Massry Conference Center, named after Morris and Esther Massry who donated $500,000 to the school's cancer research center. (Mon, 22 Oct 2007 16:44:06 GMT)

Hormone found to aid in assigning gender
A German-led study has offered hope in assigning gender for intersex people whose genital phenotypes and sex chromosomes don't match. Researchers led by Professor Paul-Martin Holterhus of University Hospital in Kiel, Germany, have shown for the first time... (Mon, 22 Oct 2007 16:52:55 GMT)

Autism Consortium releases data on genes involved in autism to researchers worldwide
The Autism Consortium, a group of researchers, clinicians and families dedicated to radically accelerating research and enhancing clinical care for autism, announced today that it has completed the first genome scan for Autism Spectrum Disorders (ASD) through its Autism Gene Discovery Project and has released the reference data set to a database that autism researchers around the world can use. ... (Mon, 22 Oct 2007 18:06:04 GMT)

Genetic Code Could Hold Key to Medical Fate
Genome mapper believes in future we'll check genetic updates with enthusiasm. (Mon, 22 Oct 2007 19:20:44 GMT)

High Throughput Genomics Receives $10 Million in Series C Financing
TUCSON, Ariz.----High Throughput Genomics, Inc., a provider of novel microplate-based gene expression assay technology and services for the pharmaceutical and life sciences industries, today announced it has closed the first tranche of its Series C financing. (Mon, 22 Oct 2007 20:00:00 GMT)

Researchers Release Genome Data on Autism
Researchers at Johns Hopkins' McKusick-Nathans Institute of Genetic Medicine today are releasing newly generated genetic data to help speed autism research. The Hopkins data, coordinated with a similar data release from the Autism Consortium, aims to help uncover the underlying hereditary factors and speed the understanding of autism by encouraging scientific collaboration. (Mon, 22 Oct 2007 20:19:56 GMT)

Tucson biotech firm gets $10 million investment
A local biotech firm has received a $10 million round of venture-capital funding, including money from a Tucson investor and a major pharmaceutical company, to expand its diagnostic product research. (Mon, 22 Oct 2007 20:33:06 GMT)

Monday's Late Winners & Losers
Apple soared in after-hours trading. (Mon, 22 Oct 2007 22:48:21 GMT)

South Alabama professor Kiene receives national grant
South Alabama marine science professor Dr. Ronald Kiene will work with a research team that was recently awarded an $864,782 grant by The National Science Foundation. The project funded by the Biological Oceanography Program of the NSF will focus on degrading organic sulfur compounds to dimethyl sulfide by use of environmental functional genomics methods. (Mon, 22 Oct 2007 22:50:34 GMT)

MRSA 'deadlier than bioweapons'
Superbugs such as MRSA pose a far greater threat to humanity than bioterrorism, a genetics scientist claims. (Tue, 23 Oct 2007 00:06:24 GMT)

Previous 1 2 3 4 5 6 7 Next